SUBSCRIBE
SUBSCRIBE
News   FDA

Boehringer Ingelheim Corporation Gets EU Nod For AIDS Drug

October 26, 2005 | 
1 min read
FRANKFURT, Oct 26 (Reuters) - Boehringer Ingelheim, Germany's top drugmaker by sales, has won European approval for its Aptivus anti-AIDS drug, the unlisted firm said on Wednesday.
FDA Approvals Europe
Boehringer Ingelheim
MORE ON THIS TOPIC
Pictured: Boehringer Ingelheim sign on a building/
Approvals
Boehringer Ingelheim Breaks Decade-Long Approval Drought in Idiopathic Pulmonary Fibrosis
October 8, 2025
 · 
2 min read
 · 
Tristan Manalac
Regulatory
Marks Finds His Next Role as Lilly Snags Another Former FDA Regulator
October 7, 2025
 · 
1 min read
 · 
Heather McKenzie
Traffic light silhouette and golden sky.
ALS
FDA Lifts Clinical Hold, Clearing Neurizon’s ALS Drug for Human Trials
October 6, 2025
 · 
2 min read
 · 
Dan Samorodnitsky
Washington, D.C., USA- January 13, 2020: FDA Sign at its headquarters in Washington DC. The Food and Drug Administration (FDA or USFDA) is a federal agency of the USA.
Manufacturing
FDA Continues US Manufacturing Drive With Domestic Generics Pilot
October 6, 2025
 · 
2 min read
 · 
Tristan Manalac